Company intelligence / Profile preview

Capcium

Dorval, Quebec, Canada

Ownership: Private
Employees: ~104
Development stage: Other

Overview

Capcium operates as a commercial contract manufacturer providing pharmaceutical-grade softgel encapsulation, formulation, development, and commercial-scale production services across pharmaceutical, OTC, nutraceutical, cannabis and cosmetics markets; it does not develop its own therapeutic pipeline but manufactures finished dosage forms for clients under GMP-like standards.

Modalities: Small moleculeBiologicNanoparticle
Industry: Contract Manufacturing Organization

Partnerships

ZYUS Life Sciences (exclusive encapsulation partner for cannabinoid softgels for the Canadian medical cannabis market via GelCan)

Beyond the preview

Go deeper on Capcium.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Capcium.

Explore the full profile